P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE

• A. Shimoni,
• C. Peczynski,
• M. Labopin,
• E. Angelucci,
• Y. Koc,
• M. Arat,
• J. Tischer,
• S. Sica,
• Z. Gülbas,
• G. Socié,
• D. Blaise,
• P. Pioltelli,
• H. Ozdogu,
• J. Vydra,
• F. Ciceri,
• A. Nagler,
• M. Mohty

Affiliations

A. Shimoni

1 bone marrow transplant and cellular therapy, Chaim Sheba Medical Center, Tel-Hashomer, Israel

C. Peczynski

2 EBMT ALWP, Paris, France

M. Labopin

2 EBMT ALWP, Paris, France

E. Angelucci

3 Ospedale San Martino, Genova, Italy

Y. Koc

4 Medicana International Hospital

M. Arat

5 Demiroglu Bilim University, Istanbul, Turkey

J. Tischer

6 Klinikum Grosshadern, Munich, Germany

S. Sica

7 Universita Cattolica S. Cuore, Istituto di Ematologia, Rome, Italy

Z. Gülbas

8 Anadolu Medical Center Hospital, Kocaeli, Turkey

G. Socié

9 Hopital St. Louis, Paris

D. Blaise

10 Institut Paoli Calmettes, Marseille, France

P. Pioltelli

11 Ospedale San Gerardo, Monza, Italy

H. Ozdogu

12 Baskent University Hospital, Adana, Turkey

J. Vydra

13 Institute of Hematology and Blood Transfusion, Prague, Czechia

F. Ciceri

14 Ospedale San Raffaele, Milano, Italy

A. Nagler

15 Chaim Sheba Medical Center, Tel-Hashomer, Israel

M. Mohty

16 Hôpital Saint-Antoine, Paris, France